Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

被引：449

作者：

Crews, K. R. ^{[1
]}

Gaedigk, A. ^{[2
,3
]}

Dunnenberger, H. M. ^{[1
]}

Leeder, J. S. ^{[2
,3
]}

Klein, T. E. ^{[4
]}

Caudle, K. E. ^{[1
]}

Haidar, C. E. ^{[1
]}

Shen, D. D. ^{[5
,6
]}

Callaghan, J. T. ^{[7
,8
]}

Sadhasivam, S. ^{[9
,10
]}

Prows, C. A. ^{[11
,12
]}

Kharasch, E. D. ^{[13
]}

Skaar, T. C. ^{[7
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA

[2] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Therapeut Innovat, Kansas City, MO USA

[3] Univ Missouri, Dept Pediat, Kansas City, MO 64110 USA

[4] Stanford Univ, Dept Genet, Stanford, CA 94305 USA

[5] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA

[6] Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA

[7] Indiana Univ Sch Med, Dept Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA

[8] RLR VA Med Ctr, Dept Vet Affairs, Indianapolis, IN USA

[9] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA

[10] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH 45229 USA

[11] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA

[12] Cincinnati Childrens Hosp Med Ctr, Div Patient Serv, Cincinnati, OH 45229 USA

[13] Washington Univ, Dept Anesthesiol, Div Clin & Translat Res, St Louis, MO USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷 / 04期

基金：

美国医疗保健研究与质量局;

关键词：

CYP2D6 ACTIVITY SCORE; BREAST-FED NEONATE; ULTRARAPID-METABOLISM; MORPHINE FORMATION; CANCER-PATIENTS; OXYCODONE; TRAMADOL; PHARMACOKINETICS; PHENOTYPE; PHARMACODYNAMICS;

D O I：

10.1038/clpt.2013.254

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 activity. Polymorphisms are a major cause of CYP2D6 variability. We summarize evidence from the literature supporting this association and provide therapeutic recommendations for codeine based on CYP2D6 genotype. This document is an update to the 2012 Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2D6 genotype and codeine therapy.

引用

页码：376 / 382

页数：7

共 50 条

[41] Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity
Bogdanos, DP
McFarlane, IG
JOURNAL OF HEPATOLOGY, 2003, 39 (05) : 860 - 863
[42] Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
Scott, S. A.
Sangkuhl, K.
Stein, C. M.
Hulot, J-S
Mega, J. L.
Roden, D. M.
Klein, T. E.
Sabatine, M. S.
Johnson, J. A.
Shuldiner, A. R.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 317 - 323
[43] Cytochrome P450 2D6 inhibitory constituents of Lunasia amara
Takahashi, Subehan Naoto
Kadota, Shigetoshi
Tezuka, Yasuhiro
PHYTOCHEMISTRY LETTERS, 2011, 4 (01) : 30 - 33
[44] A refilled substrate model for human cytochrome P450 2D6
deGroot, MJ
Bijloo, GJ
Martens, BJ
vanAcker, FAA
Vermeulen, NPE
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (01) : 41 - 48
[45] Antidepressant drugs in the elderly - Role of the cytochrome P450 2D6
Vandel, P
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (02): : 74 - 80
[46] Prediction of drug metabolism: The case of cytochrome P450 2D6
Vermeulen, NPE
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (11) : 1227 - 1239
[47] Effect of Cytochrome P450 2D6 Genotype on Maternal Paroxetine Plasma Concentrations during Pregnancy
Ververs, F. F. Tessa
Voorbij, Heronimus A. M.
Zwarts, Petra
Belitser, Svetlana V.
Egberts, Toine C. G.
Visser, Gerard H. A.
Schobben, Alfred F. A. M.
CLINICAL PHARMACOKINETICS, 2009, 48 (10) : 677 - 683
[48] Cytochrome P450 2D6 genotype partially explains interindividual pharmacokinetic variability of perazine and desmethylperazine
Brockmöller, J
Schmider, J
Sachse, C
Schley, J
Müller-Oerlinghausen, B
Roots, I
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R163 - R163
[49] Metabolic Activation of Atomoxetine Mediated by Cytochrome P450 2D6
You, Yutong
Wang, Xu
Ma, Kaiqi
Li, Jiaru
Peng, Ying
Zheng, Jiang
CHEMICAL RESEARCH IN TOXICOLOGY, 2021, 34 (09) : 2135 - 2144
[50] Rapid and reliable method for cytochrome P450 2D6 genotyping
Stamer, UM
Bayerer, B
Wolf, S
Hoeft, A
Stüber, F
CLINICAL CHEMISTRY, 2002, 48 (09) : 1412 - 1417

← 1 2 3 4 5 →